Literature DB >> 31587111

Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Seon Beom Song1, Jin Sung Park1, Gu June Chung1, In Hye Lee2, Eun Seong Hwang3.   

Abstract

BACKGROUND: Nicotinamide (NAM) is a form of vitamin B3 that, when administered at near-gram doses, has been shown or suggested to be therapeutically effective against many diseases and conditions. The target conditions are incredibly diverse ranging from skin disorders such as bullous pemphigoid to schizophrenia and depression and even AIDS. Similar diversity is expected for the underlying mechanisms. In a large portion of the conditions, NAM conversion to nicotinamide adenine dinucleotide (NAD+) may be a major factor in its efficacy. The augmentation of cellular NAD+ level not only modulates mitochondrial production of ATP and superoxide, but also activates many enzymes. Activated sirtuin proteins, a family of NAD+-dependent deacetylases, play important roles in many of NAM's effects such as an increase in mitochondrial quality and cell viability countering neuronal damages and metabolic diseases. Meanwhile, certain observed effects are mediated by NAM itself. However, our understanding on the mechanisms of NAM's effects is limited to those involving certain key proteins and may even be inaccurate in some proposed cases. AIM OF REVIEW: This review details the conditions that NAM has been shown to or is expected to effectively treat in humans and animals and evaluates the proposed underlying molecular mechanisms, with the intention of promoting wider, safe therapeutic application of NAM. KEY SCIENTIFIC CONCEPTS OF REVIEW: NAM, by itself or through altering metabolic balance of NAD+ and tryptophan, modulates mitochondrial function and activities of many molecules and thereby positively affects cell viability and metabolic functions. And, NAM administration appears to be quite safe with limited possibility of side effects which are related to NAM's metabolites.

Entities:  

Keywords:  Mitochondrial quality; NAD+; Neuroprotection; Nicotinamide; PARP-1; SIRT1

Mesh:

Substances:

Year:  2019        PMID: 31587111     DOI: 10.1007/s11306-019-1604-4

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  330 in total

1.  Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300.

Authors:  Wun-Jae Kim; Jung-Won Lee; Changyi Quan; Hyung-Joon Youn; Hwan-Mook Kim; Suk-Chul Bae
Journal:  J Urol       Date:  2011-04-21       Impact factor: 7.450

2.  A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.

Authors:  Debolina Ghosh; Kelsey R LeVault; Aaron J Barnett; Gregory J Brewer
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

3.  Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.

Authors:  Andreas S Madsen; Christian Andersen; Mohammad Daoud; Kristin A Anderson; Jonas S Laursen; Saswati Chakladar; Frank K Huynh; Ana R Colaço; Donald S Backos; Peter Fristrup; Matthew D Hirschey; Christian A Olsen
Journal:  J Biol Chem       Date:  2016-02-09       Impact factor: 5.157

4.  Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function.

Authors:  Lori Klaidman; Maria Morales; Seyha Kem; Jun Yang; Mei-Ling Chang; James D Adams
Journal:  Pharmacology       Date:  2003-11       Impact factor: 2.547

5.  Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction.

Authors:  Giulia Cipriani; Elena Rapizzi; Alfredo Vannacci; Rosario Rizzuto; Flavio Moroni; Alberto Chiarugi
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

6.  Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection.

Authors:  M F Murray; A Srinivasan
Journal:  Biochem Biophys Res Commun       Date:  1995-05-25       Impact factor: 3.575

Review 7.  Antioxidants as potential therapeutics for neuropsychiatric disorders.

Authors:  Chirayu D Pandya; Kristy R Howell; Anilkumar Pillai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-11-02       Impact factor: 5.067

8.  The effects of nicotinamide and hyperbaric oxygen on skin flap survival.

Authors:  T M Collins; R Caimi; P R Lynch; J Sheffield; A Mitra; K Stueber; Y R Smith
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1991

9.  Poly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression at the posttranscriptional level.

Authors:  S Yamagoe; T Kohda; M Oishi
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

10.  SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages.

Authors:  Ran Zhang; Hou-Zao Chen; Jin-Jing Liu; Yu-Yan Jia; Zhu-Qin Zhang; Rui-Feng Yang; Yuan Zhang; Jing Xu; Yu-Sheng Wei; De-Pei Liu; Chih-Chuan Liang
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

View more
  14 in total

Review 1.  The Role of Kynurenine Pathway and NAD+ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Mona Dehhaghi; Hamed Kazemi Shariat Panahi; Bahar Kavyani; Benjamin Heng; Vanessa Tan; Nady Braidy; Gilles J Guillemin
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

2.  Nicotinamide Supplementation during the In Vitro Maturation of Oocytes Improves the Developmental Competence of Preimplantation Embryos: Potential Link to SIRT1/AKT Signaling.

Authors:  Marwa El Sheikh; Ahmed Atef Mesalam; Muhammad Idrees; Tabinda Sidrat; Ayman Mesalam; Kyeong-Lim Lee; Il-Keun Kong
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

Review 3.  Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment.

Authors:  Eun Seong Hwang; Seon Beom Song
Journal:  Biomolecules       Date:  2020-04-29

4.  Nicotinamide, a vitamin B3 ameliorates depressive behaviors independent of SIRT1 activity in mice.

Authors:  Zhuxi Liu; Caiqin Li; Xuelian Fan; Yifang Kuang; Xu Zhang; Lei Chen; Jinjing Song; Ying Zhou; Eiki Takahashi; Guang He; Weidong Li
Journal:  Mol Brain       Date:  2020-11-23       Impact factor: 4.041

Review 5.  Effects of NAD+ in Caenorhabditis elegans Models of Neuronal Damage.

Authors:  Yuri Lee; Hyeseon Jeong; Kyung Hwan Park; Kyung Won Kim
Journal:  Biomolecules       Date:  2020-07-02

Review 6.  Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Authors:  Richard B Parsons; Paul D Facey
Journal:  Biomolecules       Date:  2021-09-28

Review 7.  The Role of Nicotinamide in Cancer Chemoprevention and Therapy.

Authors:  Ilias P Nikas; Stavroula A Paschou; Han Suk Ryu
Journal:  Biomolecules       Date:  2020-03-20

Review 8.  Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration.

Authors:  Gloria Cimaglia; Marcela Votruba; James E Morgan; Helder André; Pete A Williams
Journal:  Nutrients       Date:  2020-09-19       Impact factor: 5.717

9.  Nicotinamide inhibits melanoma in vitro and in vivo.

Authors:  Francesca Scatozza; Federica Moschella; Daniela D'Arcangelo; Stefania Rossi; Claudio Tabolacci; Claudia Giampietri; Enrico Proietti; Francesco Facchiano; Antonio Facchiano
Journal:  J Exp Clin Cancer Res       Date:  2020-10-07

Review 10.  CD38 in the age of COVID-19: a medical perspective.

Authors:  Alberto L Horenstein; Angelo C Faini; Fabio Malavasi
Journal:  Physiol Rev       Date:  2021-03-31       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.